1. CPI-0004Na, a new extracellularly tumor-activated prodrug of doxorubicin: in vivo toxicity, activity, and tissue distribution confirm tumor cell selectivity;Dubois;Cancer Res,2002
2. Extracellularly tumor-activated prodrugs for the selective chemotherapy of cancer: application to doxorubicin and preliminary in vitro and in vivo studies;Trouet;Cancer Res,2001
3. Clinical strategies for cancer treatment: the role of drugs;Kaufman,2001
4. Multidrug resistance and its reversal. General review of fundamental aspects;Robert;Ann Biol Clin,1996
5. Unraveling the role of proteases in cancer;Koblinski;Clin Chim Acta,2000